Skip to content
OpenCapital
Get started

ADMA Biologics ADMA Increase (Decrease) in Deferred Income Taxes

Increase (Decrease) in Deferred Income Taxes at other companies

Zymeworks logo
ZymeworksZYME
$2.2M+437%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's increase (decrease) in deferred income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's increase (decrease) in deferred income taxes?
ADMA Biologics (ADMA) reported increase (decrease) in deferred income taxes of -$2.76M in Q4 2025.
How has ADMA Biologics's increase (decrease) in deferred income taxes changed year-over-year?
ADMA Biologics's increase (decrease) in deferred income taxes decreased by 113.1% year-over-year, from $21.07M to -$2.76M.
What does increase (decrease) in deferred income taxes mean?
This represents the change in deferred tax assets or liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities. It provides insight into future tax obligations or benefits that will reverse in subsequent periods.